He Yong, Chen Shiyun, Li Mengmeng, Gao Yonghao, Feng Huiyi, Umar Qasim, Yin Dengke, Feng Yisi
School of Chemistry and Chemical Engineering, Hefei University of Technology, Hefei, China.
Analytical & Testing Center, Hefei University, Hefei, China.
Drug Dev Ind Pharm. 2023 Oct;49(10):617-627. doi: 10.1080/03639045.2023.2259460. Epub 2023 Nov 9.
To synthesis a novel 'Pharmaceutical Cocrystal' of berberine (BBR) with coformer 3-methylcinnamic acid (3MCA) for increasing its solubility and intestinal absorption property.
BBR-HCl has poor liposolubility, difficulty in penetrating the cell membrane and absorption in the gastrointestinal tract, low bioavailability, and limited clinical application. A new cocrystal is formed by the interaction between 3-MCA and BBR through molecular interaction, which improves the physicochemical properties, intestinal absorption property, and hygroscopicity.
The solvent evaporation method was used to synthesize BCR-3MCA cocrystal. The physicochemical properties of the crystals were confirmed by different spectral techniques, i.e. by X-ray diffraction (PXRD, SXRD), thermogravimetry and differential thermal analysis (DSC, TGA), and scanning electron microscopy (SEM). Hygroscopicity of the cocrystal was evaluated by dynamic water vapor sorption (DVS). The intestinal absorption property was evaluated by the Ussing chamber system.
BBR and 3MCA can be directly self-assembled into uniform co-crystal by hydrogen bonds and π-π stacking interactions. Compared with BBR-HCl, the solubility of BBR-3MCA cocrystal in polar solvents of water, methanol, ethanol, and isopropanol increased by 13.9, 1.5, 4.7, and 15.8 times, respectively. The apparent absorption and the absorption rate constants were increased by 7.7 and 5.6 times, respectively. Surprisingly, BBR-3MCA co-crystal almost had no hygroscopicity.
The absolute molecular structure of the co-crystal was further confirmed by single crystal X-ray diffraction. The hydrogen bonds drove the formation of X-like one-dimensional unit. Compared to the BBR-HCl, BBR-3MCA cocrystal displayed superior dissolution and solubility performance, improved physical-chemical properties and significantly improved intestinal absorption.
合成一种新型的小檗碱(BBR)与共形成物3-甲基肉桂酸(3MCA)的“药物共晶”,以提高其溶解度和肠道吸收性能。
盐酸小檗碱脂溶性差,难以穿透细胞膜并在胃肠道吸收,生物利用度低,临床应用受限。3-甲基肉桂酸与小檗碱通过分子间相互作用形成新的共晶,改善了其理化性质、肠道吸收性能和吸湿性。
采用溶剂蒸发法合成BCR-3MCA共晶。通过不同的光谱技术,即X射线衍射(粉末X射线衍射、单晶X射线衍射)、热重分析和差示热分析(差示扫描量热法、热重分析法)以及扫描电子显微镜(扫描电子显微镜)来确认晶体的理化性质。通过动态水蒸气吸附(动态水蒸气吸附仪)评估共晶的吸湿性。通过Ussing chamber系统评估肠道吸收性能。
BBR和3MCA可通过氢键和π-π堆积相互作用直接自组装成均匀的共晶。与盐酸小檗碱相比,BBR-3MCA共晶在水、甲醇、乙醇和异丙醇等极性溶剂中的溶解度分别提高了13.9倍、1.5倍、4.7倍和15.8倍。表观吸收和吸收速率常数分别提高了7.7倍和5.6倍。令人惊讶的是,BBR-3MCA共晶几乎没有吸湿性。
通过单晶X射线衍射进一步证实了共晶的绝对分子结构。氢键驱动形成X型一维单元。与盐酸小檗碱相比,BBR-3MCA共晶表现出优异的溶解和溶解性能,改善了理化性质,并显著提高了肠道吸收。